See every side of every news story
Published loading...Updated

FDA nominee sidesteps questions on abortion pill, agency layoffs and other issues

  • During his confirmation hearing, Dr. Marty Makary responded to questions about regulatory processes and the FDA's handling of vaccine meetings, citing examples of missed opportunities for discussion from other political administrations.
  • Senator Patty Murray expressed concern over the FDA's canceled vaccine meeting, stating it undermines public health recommendations that have existed for decades.
  • Makary faced inquiries about the mifepristone abortion pill but refrained from making firm commitments regarding its regulatory status, emphasizing the need to review data first.
  • Amid staffing changes, including recent layoffs, Makary's nomination is timely, with pressure on the FDA from various sides regarding its decision-making processes and transparency.
Insights by Ground AI
Does this summary seem wrong?

79 Articles

All
Left
21
Center
26
Right
13
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 43% of the sources are Center
43% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endpoints News broke the news in on Wednesday, March 5, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.